iHuman Inc. (IH)
| Market Cap | 71.56M |
| Revenue (ttm) | 115.38M |
| Net Income (ttm) | 13.64M |
| Shares Out | 51.11M |
| EPS (ttm) | 0.26 |
| PE Ratio | 5.44 |
| Forward PE | n/a |
| Dividend | $0.10 (7.14%) |
| Ex-Dividend Date | Apr 17, 2026 |
| Volume | 1,903 |
| Open | 1.380 |
| Previous Close | 1.380 |
| Day's Range | 1.380 - 1.400 |
| 52-Week Range | 1.330 - 3.600 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 10, 2026 |
About IH
iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI... [Read more]
Financial Performance
In 2025, iHuman's revenue was 807.02 million, a decrease of -12.49% compared to the previous year's 922.20 million. Earnings were 95.40 million, a decrease of -3.23%.
Financial numbers in CNY Financial StatementsNews
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
New late-breaking data presentations underscore Jazz's significant progress in advancing holistic understanding of narcolepsy and idiopathic hypersomnia, including novel real-world evidence of meaning...
iHuman acquires businesses related to All Knowledge, Perfect Lingo for RMB 94M
iHuman (IH) announced that it has entered into certain asset transfer agreements to acquire the businesses and assets related to two products, All Knowledge and Perfect Lingo, for an aggregate…
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
BEIJING, May 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it has en...
iHuman Inc. Files 2025 Annual Report on Form 20-F
BEIJING, April 24, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it file...
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results
BEIJING , Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
Beijing, China--(Newsfile Corp. - November 24, 2025) - iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor Relatio...
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
BEIJING , Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman and Cricket Media Team Up to Launch Reading Stars
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va.
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results
BEIJING , June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Files 2024 Annual Report on Form 20-F
BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it fil...
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
BEIJING , March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results
BEIJING , Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman reports Q2 revenue RMB215.1M vs. RMB241M last year
Reports Q2 net income RMB24.7M vs. RMB42.1M last year. Average total MAUs for the second quarter were 24.57M, a year-over-year increase of 20.8%. Dr. Peng Dai, Director and CEO of…
iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results
BEIJING , Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman reports Q1 revenue RMB 235M vs. RMB 265.2M last year
Average total MAUs reached a record-high of 26.38M, a year-over-year increase of 25.1%. Peng Dai, director and CEO of iHuman, commented, “We started 2024 on a positive note, as our…
iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results
BEIJING , June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Files 2023 Annual Report on Form 20-F
BEIJING , April 25, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it fil...
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
BEIJING , Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Issues First Environmental, Social and Governance (ESG) Report
BEIJING , Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today published its first en...
iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results
BEIJING , Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Announces Second Quarter 2023 Unaudited Financial Results
BEIJING , Sept. 21, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman's Vivien Wang Recognized as CFO of the Year 2022-2023
BEIJING , Aug. 4, 2023 /PRNewswire/ -- Ms. Vivien Wang, Director and Chief Financial Officer (CFO) of iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectu...
iHuman Inc. Announces First Quarter 2023 Unaudited Financial Results
BEIJING , June 21, 2023 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...